124 related articles for article (PubMed ID: 26685324)
1. The chimeric transcript RUNX1-GLRX5: a biomarker for good postoperative prognosis in Stage IA non-small-cell lung cancer.
Ishikawa R; Amano Y; Kawakami M; Sunohara M; Watanabe K; Kage H; Ohishi N; Yatomi Y; Nakajima J; Fukayama M; Nagase T; Takai D
Jpn J Clin Oncol; 2016 Feb; 46(2):185-9. PubMed ID: 26685324
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer.
Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M
Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820
[TBL] [Abstract][Full Text] [Related]
3. A clinicopathologic prediction model for postoperative recurrence in stage Ia non-small cell lung cancer.
Zhang Y; Sun Y; Xiang J; Zhang Y; Hu H; Chen H
J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1193-9. PubMed ID: 24667022
[TBL] [Abstract][Full Text] [Related]
4. A three gene-based risk score predicts prognosis of resected non-small-cell lung cancer.
Liu K; Chen HL; Gu MM; You QS
Int J Clin Exp Pathol; 2015; 8(12):16081-8. PubMed ID: 26884885
[TBL] [Abstract][Full Text] [Related]
5. Postoperative serum carcinoembryonic antigen levels in patients with pathologic stage IA nonsmall cell lung carcinoma: subnormal levels as an indicator of favorable prognosis.
Sawabata N; Maeda H; Yokota S; Takeda S; Koma M; Tokunaga T; Ito M
Cancer; 2004 Aug; 101(4):803-9. PubMed ID: 15305413
[TBL] [Abstract][Full Text] [Related]
6. Expression of p63, TTF-1 and Maspin in Non-Small Cell Lung Carcinoma and Their Effect on the Prognosis and Differential Diagnosis.
Yaman B; Nart D; Ekren PK; Çok G; Veral A
Turk Patoloji Derg; 2015; 31(3):163-74. PubMed ID: 26456962
[TBL] [Abstract][Full Text] [Related]
7. Pathological vascular invasion and tumor differentiation predict cancer recurrence in stage IA non-small-cell lung cancer after complete surgical resection.
Shimada Y; Saji H; Yoshida K; Kakihana M; Honda H; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
J Thorac Oncol; 2012 Aug; 7(8):1263-70. PubMed ID: 22673056
[TBL] [Abstract][Full Text] [Related]
8. Predictive Impact for Postoperative Recurrence of Preoperative Serum Krebs von den Lungen-6 Concentration in Pathologic Stage IA Non-Small Cell Lung Cancer.
Shoji F; Yamazaki K; Kouso H; Mori R; Takeo S
Ann Thorac Surg; 2016 May; 101(5):1903-8. PubMed ID: 26912302
[TBL] [Abstract][Full Text] [Related]
9. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis as a prognostic factor for stage IA non-small cell lung cancer.
Park SY; Lee HS; Jang HJ; Lee GK; Chung KY; Zo JI
Ann Thorac Surg; 2011 Jun; 91(6):1668-73. PubMed ID: 21619963
[TBL] [Abstract][Full Text] [Related]
11. Upstaging by vessel invasion improves the pathology staging system of non-small cell lung cancer.
Tsuchiya T; Hashizume S; Akamine S; Muraoka M; Honda S; Tsuji K; Urabe S; Hayashi T; Yamasaki N; Nagayasu T
Chest; 2007 Jul; 132(1):170-7. PubMed ID: 17505030
[TBL] [Abstract][Full Text] [Related]
12. Survival after pathological stage IA nonsmall cell lung cancer: tumor size matters.
Birim O; Kappetein AP; Takkenberg JJ; van Klaveren RJ; Bogers AJ
Ann Thorac Surg; 2005 Apr; 79(4):1137-41. PubMed ID: 15797040
[TBL] [Abstract][Full Text] [Related]
13. Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer.
Huang Y; Liu Z; He L; Chen X; Pan D; Ma Z; Liang C; Tian J; Liang C
Radiology; 2016 Dec; 281(3):947-957. PubMed ID: 27347764
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of resectable non-small cell lung cancer: post-resection serum samples may be useful in identifying potential markers.
Rathinam S; Ward DG; James ND; Rajesh PB
Interact Cardiovasc Thorac Surg; 2011 Jul; 13(1):3-6. PubMed ID: 21525028
[TBL] [Abstract][Full Text] [Related]
15. Factors predicting poor survival after resection of stage IA non-small cell lung cancer.
Paleari L; Russo P; Cesario A; Granone P
J Thorac Cardiovasc Surg; 2008 Jul; 136(1):241-2. PubMed ID: 18603108
[No Abstract] [Full Text] [Related]
16. New positron emission tomography derived parameters as predictive factors for recurrence in resected stage I non-small cell lung cancer.
Melloni G; Gajate AM; Sestini S; Gallivanone F; Bandiera A; Landoni C; Muriana P; Gianolli L; Zannini P
Eur J Surg Oncol; 2013 Nov; 39(11):1254-61. PubMed ID: 23948705
[TBL] [Abstract][Full Text] [Related]
17. Limited resection for clinical Stage IA non-small-cell lung cancers based on a standardized-uptake value index.
Shiono S; Abiko M; Sato T
Eur J Cardiothorac Surg; 2013 Jan; 43(1):e7-e12. PubMed ID: 23129358
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of clinical/pathological stage IA non-small-cell lung cancer showing partially solid or solid tumours on radiological exam.
Uehara H; Matsuura Y; Nakao M; Mun M; Nakagawa K; Ishikawa Y; Okumura S
Ann Thorac Cardiovasc Surg; 2015; 21(4):338-44. PubMed ID: 25740451
[TBL] [Abstract][Full Text] [Related]
19. Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy.
Tokito T; Azuma K; Kawahara A; Ishii H; Yamada K; Matsuo N; Kinoshita T; Mizukami N; Ono H; Kage M; Hoshino T
Eur J Cancer; 2016 Mar; 55():7-14. PubMed ID: 26771872
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of Lewis related antigen expression in stage I non-small cell lung cancer.
Ogawa J; Inoue H; Koide S
Eur J Cancer; 1995 Sep; 31A(10):1716. PubMed ID: 7488433
[No Abstract] [Full Text] [Related]
[Next] [New Search]
